rs2028414

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BA1

The NM_001112726.3(CEP170B):​c.594A>C​(p.Pro198Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.627 in 1,529,066 control chromosomes in the GnomAD database, including 306,830 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).

Frequency

Genomes: 𝑓 0.59 ( 27392 hom., cov: 27)
Exomes 𝑓: 0.63 ( 279438 hom. )

Consequence

CEP170B
NM_001112726.3 synonymous

Scores

2

Clinical Significance

Benign no assertion criteria provided B:1

Conservation

PhyloP100: -1.83

Publications

28 publications found
Variant links:
Genes affected
CEP170B (HGNC:20362): (centrosomal protein 170B) Predicted to be located in cytoplasm and microtubule. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BP6
Variant 14-104883051-A-C is Benign according to our data. Variant chr14-104883051-A-C is described in ClinVar as Benign. ClinVar VariationId is 3058875.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=-1.84 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.647 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CEP170BNM_001112726.3 linkc.594A>C p.Pro198Pro synonymous_variant Exon 8 of 19 ENST00000414716.8 NP_001106197.1 Q9Y4F5-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CEP170BENST00000414716.8 linkc.594A>C p.Pro198Pro synonymous_variant Exon 8 of 19 1 NM_001112726.3 ENSP00000404151.2 Q9Y4F5-2
CEP170BENST00000556508.5 linkc.384A>C p.Pro128Pro synonymous_variant Exon 7 of 18 5 ENSP00000451249.1 Q9Y4F5-3

Frequencies

GnomAD3 genomes
AF:
0.593
AC:
89474
AN:
150994
Hom.:
27392
Cov.:
27
show subpopulations
Gnomad AFR
AF:
0.509
Gnomad AMI
AF:
0.632
Gnomad AMR
AF:
0.586
Gnomad ASJ
AF:
0.704
Gnomad EAS
AF:
0.219
Gnomad SAS
AF:
0.612
Gnomad FIN
AF:
0.667
Gnomad MID
AF:
0.782
Gnomad NFE
AF:
0.652
Gnomad OTH
AF:
0.626
GnomAD2 exomes
AF:
0.578
AC:
84752
AN:
146532
AF XY:
0.586
show subpopulations
Gnomad AFR exome
AF:
0.498
Gnomad AMR exome
AF:
0.527
Gnomad ASJ exome
AF:
0.703
Gnomad EAS exome
AF:
0.202
Gnomad FIN exome
AF:
0.663
Gnomad NFE exome
AF:
0.641
Gnomad OTH exome
AF:
0.610
GnomAD4 exome
AF:
0.631
AC:
869874
AN:
1377952
Hom.:
279438
Cov.:
64
AF XY:
0.631
AC XY:
428088
AN XY:
678104
show subpopulations
African (AFR)
AF:
0.505
AC:
15917
AN:
31516
American (AMR)
AF:
0.542
AC:
19294
AN:
35614
Ashkenazi Jewish (ASJ)
AF:
0.700
AC:
16893
AN:
24124
East Asian (EAS)
AF:
0.176
AC:
6410
AN:
36382
South Asian (SAS)
AF:
0.620
AC:
48662
AN:
78434
European-Finnish (FIN)
AF:
0.658
AC:
24454
AN:
37170
Middle Eastern (MID)
AF:
0.733
AC:
4080
AN:
5568
European-Non Finnish (NFE)
AF:
0.652
AC:
698647
AN:
1071864
Other (OTH)
AF:
0.620
AC:
35517
AN:
57280
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
18515
37031
55546
74062
92577
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18594
37188
55782
74376
92970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.592
AC:
89504
AN:
151114
Hom.:
27392
Cov.:
27
AF XY:
0.590
AC XY:
43557
AN XY:
73772
show subpopulations
African (AFR)
AF:
0.509
AC:
20913
AN:
41112
American (AMR)
AF:
0.585
AC:
8894
AN:
15196
Ashkenazi Jewish (ASJ)
AF:
0.704
AC:
2431
AN:
3454
East Asian (EAS)
AF:
0.219
AC:
1123
AN:
5130
South Asian (SAS)
AF:
0.613
AC:
2904
AN:
4736
European-Finnish (FIN)
AF:
0.667
AC:
7007
AN:
10498
Middle Eastern (MID)
AF:
0.772
AC:
227
AN:
294
European-Non Finnish (NFE)
AF:
0.652
AC:
44129
AN:
67698
Other (OTH)
AF:
0.623
AC:
1303
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1721
3442
5162
6883
8604
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
730
1460
2190
2920
3650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.629
Hom.:
103932
Bravo
AF:
0.582
Asia WGS
AF:
0.413
AC:
1440
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

CEP170B-related disorder Benign:1
Oct 17, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.99
CADD
Benign
0.44
DANN
Benign
0.48
PhyloP100
-1.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2028414; hg19: chr14-105349388; COSMIC: COSV69024171; API